October is Breast Cancer Awareness Month, an annual campaign dedicated to raising awareness and reflecting on the progress in breast cancer research, ...
Decentralized clinical trials (DCTs) and virtual clinical trials helped bring in agility in the clinical trial industry. With innovations such as wear...
As a premier pharmacovigilance CRO, we offer an array of pharmacovigilance services tailored to meet the specific needs of pharmaceutical companies ac...
Open-source data analytics tools are transforming industries, particularly healthcare and clinical trials, by offering cost-effective and flexible sol...
First-in-human (FIH) clinical trials mark a significant turning point in drug development, where a new therapy moves from the lab to being tested in h...
At Navitas Life Sciences, we understand the immense impact cardiovascular diseases have on global health, making advancements in treatment essential. ...
Alzheimer’s disease stands as one of the most challenging medical puzzles of our time, affecting millions of people globally. As a progressive ...
Navitas Life Sciences offers comprehensive regulatory services that empower pharmaceutical, biotechnology, and medical device companies to meet string...
At Navitas Life Sciences, we pride ourselves on being at the forefront of providing comprehensive medical and regulatory consulting services that help...
In the intricate world of pharmaceutical development, where the stakes are high, deadlines are tight, and precision is non-negotiable, the role of med...
Designing complex innovative protocols for Oncology clinical trials is a complex process that must balance scientific rigor, regulatory requirements, ...
Driving transformation in the drug development landscape requires more than just adapting to changes; it demands leading them. At Navitas Life Science...
As we mark Immunization Awareness Month 2024, it's imperative to spotlight the critical role of vaccines in public health and the intricate processes ...
The recent announcement by the US Food and Drug Administration (FDA) regarding laboratory-developed tests (LDTs) indicates that increased enforcement ...
The recent shift in the UK's regulatory landscape, marked by the adoption of the International Recognition Procedure (IRP) by the Medicines and Health...
At Navitas Life Sciences, we are at the forefront of providing comprehensive regulatory services that ensure compliance, accelerate time-to-market, an...
How Navitas Life Sciences grew to be a Strategic Partner for Top Pharma across the World Clinical trials are the backbone of modern medical advancemen...
The global clinical trials market, valued at USD 80.7 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 6.49% from 2024...
By reimagining regulatory submission strategies with artificial intelligence in regulatory affairs, pharmaceutical companies can expedite timelines an...
At Navitas Life Sciences, we believe in not just advancing the frontiers of pharmaceutical sciences but also in giving back to society and academia. D...